COMING SOON: 2022 Year-in-Review Industry Reports

It has been quite a year for the psychedelics industry. We’ve experienced our fair share of ups and downs, opportunities and uncertainties, and a great deal of forward progress. With so much going on all the time, it can be tough to keep up.

That’s why we strive to do all the research necessary to publish a myriad of industry reports every year.

Before January 1st, we’ll be releasing all of our end-of-year psychedelics industry reports. In order to bring these reports to fruition, we’ve scoured the planet to find the best and most reliable data and information on the psychedelics sector.

Alongside the individual release of each report, there will be an option to either buy the individual report or subscribe to an annual Psychedelic Invest PRO account.

For more information on the new and improved Psychedelic Invest PRO, you can view more details by clicking the image below.

No matter your role, job description, or level of interest in the psychedelics sector, one of these reports will surely equip you with everything you need to know on the topic at hand. See below for the complete list of reports and what to expect from each.

Are you having trouble keeping track of all the clinical trials, what phases they’re in, where they’re located, and which organizations are leading the way? This report was designed to lay it all out simply yet exhaustively for anyone to understand.

With the market as volatile as it is today, the largest companies in the psychedelics industry have pulled back on spending. But that doesn’t mean they’ve stopped hiring. Gather information on which organizations are growing, what jobs are in most demand, and how these roles can foreshadow what to expect from the industry in the future.

Note: This is a great report for anyone looking to break into the psychedelics industry.

If you’ve ever wondered where capital is being allocated in the market, this is the report for you. Get a glimpse into all of the firms, their portfolio companies, and everything that informs any investor where the momentum is moving. After all, are there any better strategies than following where the money is flowing?

Neuly, Psychedelic Invest’s sister company, offers the widest and most detailed array of data points on the psychedelics industry. Our team has indexed all of the organizations inside of Neuly and created this report as a reference to anyone looking to better understand all of the players, what they’re working on, and how they’re uniquely positioned in the market.

I’m sure most of you are big fans and followers of our Psychedelic Stock Index (we sure use it!). With all of the data jam-packed within that index, we were able to provide a holistic view of all of the public companies. To make it even more compelling, we even designed Technical Analysis charts that will surely entice any psychedelic market stock trader out there.

Who are the nonprofit organizations and charities providing services and resources to the thriving psychedelics industry? You’ll find that and more inside the Psychedelic Invest Nonprofits Report.

If you’re reading this, you hopefully don’t need to be convinced that psychedelics can have profound effects on the human mind and psyche. In the Medicinal Treatments Report, the Psychedelic Invest team breaks down which compound is treating which indication and what that might mean for healthcare as a whole in the future.

The psychedelics industry has been clamoring about one obvious void that everyone seems to be concerned about. This void is serving as an unfortunate bottleneck for the future growth of the sector. What’s the void? Educated practitioners. What’s the solution? Educational organizations teach courses that empower future practitioners with knowledge and expertise in psychedelic-assisted therapies.

The science of psychedelics is constantly evolving. This makes it critical that all data is captured, stored, and distributed in a reliable and efficient way. So who is being all of the research? This report dives in deeper to unpack all of the ins and outs of psychedelic research and the organizations tasked with combing through all of the data.

Psychedelics seem to be moving at a breakneck speed these days. How can one be expected to keep up? One of the more difficult aspects to stay on top of is the decriminalization and legalization of psychedelics across states, countries, and local municipalities. Leave it to the Psychedelic Invest Legal Report to zoom in on all of the considerations so that you can stay in the know regarding everything that’s taking place in the world.

Annual subscriptions to Psychedelic Invest PRO are now $999. If you’d like full access to all of these reports, subscribing is your best option. Otherwise, each of these reports will be available for $499.